Want to see HK:0399 full AI Analyst Report?

Innovative Pharmaceutical Biotech (0399) Financial Statements

0 Followers

Innovative Pharmaceutical Biotech Financial Overview

Innovative Pharmaceutical Biotech's market cap is currently HK$231.21M. The company's EPS TTM is HK$-0.3197; its P/E ratio is -0.23; Innovative Pharmaceutical Biotech is scheduled to report earnings on June 30, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	HK$ 2.09M	HK$ 6.59M	HK$ 8.07M	HK$ 11.14M	HK$ 15.19M
Gross Profit	HK$ 188.00K	HK$ 840.00K	HK$ 858.00K	HK$ 1.05M	HK$ 1.41M
Operating Income	HK$ -13.26M	HK$ -13.43M	HK$ -20.70M	HK$ -24.35M	HK$ -21.34M
EBITDA	HK$ -310.25M	HK$ 317.75M	HK$ -18.82M	HK$ 228.51M	HK$ -18.81M
Net Income	HK$ -345.94M	HK$ 103.40M	HK$ -245.70M	HK$ 296.54M	HK$ -395.75M
Balance Sheet
Cash & Short-Term Investments	HK$ 3.70M	HK$ 3.08M	HK$ 1.33M	HK$ 4.08M	HK$ 8.99M
Total Assets	HK$ 1.09B	HK$ 1.38B	HK$ 1.38B	HK$ 1.39B	HK$ 1.40B
Total Debt	HK$ 1.00B	HK$ 1.01B	HK$ 1.19B	HK$ 941.84M	HK$ 991.48M
Net Debt	HK$ 999.77M	HK$ 1.01B	HK$ 1.19B	HK$ 937.76M	HK$ 982.49M
Total Liabilities	HK$ 1.06B	HK$ 1.06B	HK$ 1.24B	HK$ 999.73M	HK$ 1.04B
Stockholders' Equity	HK$ -681.19M	HK$ -611.51M	HK$ -795.07M	HK$ -549.37M	HK$ -595.35M
Cash Flow
Free Cash Flow	HK$ -10.55M	HK$ -8.28M	HK$ -17.64M	HK$ -12.34M	HK$ -25.01M
Operating Cash Flow	HK$ -10.55M	HK$ -8.28M	HK$ -17.64M	HK$ -12.34M	HK$ -25.01M
Investing Cash Flow	HK$ 0.00	HK$ 0.00	HK$ 0.00	HK$ -1.00K	HK$ 13.00K
Financing Cash Flow	HK$ 11.19M	HK$ 10.32M	HK$ 14.92M	HK$ 7.30M	HK$ 10.57M

Currency in HKD

Innovative Pharmaceutical Biotech Earnings and Revenue History

Income Statement >

Innovative Pharmaceutical Biotech Debt to Assets

Balance Sheet >

Innovative Pharmaceutical Biotech Cash Flow

Cash Flow >

Innovative Pharmaceutical Biotech Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >